BACKGROUND: The etiology of thrombocytopenia during infancy and early childhood may
be different from that of older children, because young children frequently receive vaccines …

OBJECTIVE. The objective of this study was to identify risk factors for developing chronic
idiopathic thrombocytopenic purpura in a cohort of pediatric patients with idiopathic …

This case–control study investigated immune thrombocytopenic purpura (ITP) risk following
live, inactivated, and simultaneous vaccination, with a focus on infants aged< 2 years. We …

BACKGROUND: The risk of immune thrombocytopenic purpura (ITP) after childhood
vaccines other than measles-mumps-rubella vaccine (MMR) is unknown. METHODS: Using …

Patients who presented with purpura and blood platelets< 30× 109/l within 1 month after
vaccination were collected from a population based material of 506 consecutive pediatric …

In the literature, patients developing thrombocytopenic purpura following rubella, measles,
cytomegalovirus (CMV), or Epstein-Barr virus (EBV) infections or rubella, measles, or …

In the adult age group, vaccines did not contribute to the development of immune
thrombocytopenia (ITP), but an increase was reported in diphtheria-tetanus-pertussis …

The most important reasons cited by the opponents of vaccines are concerns about vaccine
safety. Unlike issues such as autism for which no indisputable documentation of direct …

An increasing body of evidence has been gathered since the mid-1960s to support a link
between vaccinations, particularly the measles-mumps-rubella (MMR) vaccine and …

Background. Thrombocytopenia occasionally follows immunization of children, especially
after administration of measles-containing vaccines. The purpose of this study was to …